GMP Audits Reveal 22 Percent Failure Rate for HPTLC Identity Testing of Botanical Extracts

European GMP auditors are shifting focus from heavy metal contaminants to raw material identity verification for botanical extracts. Data from Q2 2026 audits shows a 22 percent non-compliance rate specifically regarding the use of non-specific identity tests like organoleptic evaluation or simple UV-Vis spectrophotometry for complex extracts.

Audit Targets for Identity Verification

Regulators now expect High-Performance Thin-Layer Chromatography (HPTLC) for every batch of botanical raw material. Relying on a supplier COA is no longer considered adequate due diligence under current interpretations of Annex 1. Recent findings highlight three main failure points in procurement documentation.

• Lack of reference standards for marker compounds in Ashwagandha and Rhodiola extracts.
• Inability to differentiate between specific plant parts such as root versus leaf in extract profiles.
• Failure to verify the absence of common adulterants in high-value powders like Saffron.

Cost Impact of Compliance Upgrades

Switching to labs that provide full HPTLC fingerprinting adds approximately 140 EUR to 210 EUR per batch in testing costs. While this increases the overhead for small-batch runs, it is cheaper than a product recall or a suspended manufacturing license. If you are sourcing Ginkgo Biloba or Curcumin, the risk of adulteration makes these audits particularly aggressive.

Procurement managers should renegotiate supply contracts to include HPTLC chromatograms with every delivery. If your current contract manufacturer cannot provide these internally, expect a 12 percent hike in quality control fees as they outsource this to third-party labs like Eurofins or SGS.